
1. Infection. 2021 Nov 25. doi: 10.1007/s15010-021-01731-5. [Epub ahead of print]

Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the
first wave of the pandemic in France.

Carrat F(1), Lapidus N(2), Ninove L(3), Blanché H(4), Rahib D(5), Saba Villarroel
PM(3), Touvier M(6), Severi G(7)(8), Zins M(9)(10), Deleuze JF(4), de Lamballerie
X(3); SAPRIS-SERO study group.

Collaborators: Carrat F, Ancel PY, Charles MA, Severi G, Touvier M, Zins M, Bajos
N, Jusot F, Martin C, Meyer L, Pailhé A, Rouquette A, Spire A, Kab S, Renuy A,
Le-Got S, Ribet C, Wiernik E, Goldberg M, Artaud F, Gerbouin-Rérolle P, Enguix M,
Laplanche C, Gomes-Rima R, Hoang L, Correia E, Barry AA, Senina N, Allegre J,
Szabo de Edelenyi F, Druesne-Pecollo N, Esseddik Y, Hercberg S, Benhammou V,
Ritmi A, Marchand L, Zaros C, Lordmi E, Candea A, de Visme S, Simeon T, Thierry
X, Geay B, Dufourg MN, Milcent K, Rahib D, Lydie N, Lusivika-Nzinga C, Pannetier 
G, Lapidus N, Goderel I, Dorival C, Nicol J, Lai C, Belhadji L, Esperou H,
Couffin-Cadiergues S, Gagliolo JM, Blanché H, Sébaoun JM, Beaudoin JC, Gressin L,
Morel V, Ouili O, Deleuze JF, Ninove L, Priet S, Saba Villarroel PM, Fourié T,
Ali SM, Amroun A, Seston M, Ayhan N, Pastorino B, de Lamballerie X.

Author information: 
(1)Sorbonne Université, Inserm, Institut Pierre-Louis d'Épidémiologie et de Santé
Publique, Département de Santé Publique, APHP.Sorbonne Université, 27 rue
Chaligny, 75571, Paris Cedex 12, France. fabrice.carrat@iplesp.upmc.fr.
(2)Sorbonne Université, Inserm, Institut Pierre-Louis d'Épidémiologie et de Santé
Publique, Département de Santé Publique, APHP.Sorbonne Université, 27 rue
Chaligny, 75571, Paris Cedex 12, France.
(3)Unité des Virus Émergents, UVE, Aix Marseille Univ, IRD 190, INSERM 1207, IHU 
Méditerranée Infection, 13005, Marseille, France.
(4)Fondation Jean Dausset-CEPH (Centre d'Etude du Polymorphisme Humain),
CEPH-Biobank, Paris, France.
(5)Santé Publique France, Saint-Maurice, France.
(6)Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional
Epidemiology Research Team (EREN), Epidemiology and Statistics Research
Center-University of Paris (CRESS), Bobigny, France.
(7)CESP UMR1018, Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy,
Villejuif, France.
(8)Department of Statistics, Computer Science and Applications, University of
Florence, Florence, Italy.
(9)Paris University, Paris, France.
(10)Université Paris-Saclay, Université de Paris, UVSQ, Inserm UMS 11, Villejuif,
France.

BACKGROUND: The interplay between age and symptoms intensity on antibody response
to SARS-CoV-2 infection has not been studied in a general population setting.
METHODS: We explored the serologic profile of anti-SARS-CoV-2 antibodies after
the first wave of the pandemic, by assessing IgG against the spike protein
(ELISA-S), IgG against the nucleocapsid protein (ELISA-NP) and neutralizing
antibodies (SN) in 82,126 adults from a French population-based multi-cohort
study.
RESULTS: ELISA-S positivity was increased in 30- to 49-year-old adults (8.5%)
compared to other age groups (5.6% in 20- to 29-year-olds, 2.8%
in ≥ 50-year-olds). In the 3681 ELISA-S positive participants, ELISA-NP and SN
positivity exhibited a U-shaped relationship with age, with a lower rate in 30-
to 49-year-old adults, and was strongly associated with COVID-19-like symptoms.
CONCLUSION: Our study confirms the independent role of age and symptoms on the
serologic profile of anti-SARS-CoV-2 antibodies, but the non-linear relationship 
with age deserves further investigation.

© 2021. The Author(s).

DOI: 10.1007/s15010-021-01731-5 
PMCID: PMC8614216
PMID: 34822130 

